IRIS
XUE, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 220
EU - Europa 192
AS - Asia 96
OC - Oceania 1
SA - Sud America 1
Totale 510
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 218
IT - Italia 107
CN - Cina 56
SE - Svezia 54
SG - Singapore 30
RU - Federazione Russa 17
IN - India 7
DE - Germania 5
FI - Finlandia 3
HK - Hong Kong 3
AT - Austria 2
AU - Australia 1
BR - Brasile 1
CA - Canada 1
ES - Italia 1
GB - Regno Unito 1
IE - Irlanda 1
MX - Messico 1
NL - Olanda 1
Totale 510
Salva come PNG Salva come JPEG
Città #
Milan 43
New York 31
Ashburn 29
Shanghai 21
Singapore 17
Moscow 12
Chandler 9
Lawrence 9
Princeton 9
Rome 9
Boardman 7
Pune 7
Bologna 5
Dallas 5
Beijing 4
Pisa 4
Seattle 4
Brescia 3
Genoa 3
Shenzhen 3
Avellino 2
Borgomanero 2
Carpenedolo 2
Castelseprio 2
Chaoyang 2
Cinisello Balsamo 2
Helsinki 2
Hong Kong 2
Newark 2
Ome 2
Santa Clara 2
Verona 2
Vienna 2
Washington 2
Baoding 1
Buffalo 1
Carugate 1
Changsha 1
Cormano 1
Dublin 1
Elmendorf 1
Jiaxing 1
Kassel 1
Laojunmiao 1
Lappeenranta 1
Logroño 1
Los Angeles 1
Macerata 1
Mexico City 1
Miami 1
Nuremberg 1
Sydney 1
São Paulo 1
Toronto 1
Wuhan 1
Wuxi 1
Totale 284
Salva come PNG Salva come JPEG
Nome #
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia 52
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 35
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 32
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 29
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 28
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study 26
Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide 26
Quantitative polymerase chain reaction-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study 26
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome 25
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation 24
Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial 23
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant 23
Defibrotide Prophylaxis of Sinusoidal Obstruction Syndrome in Adults Treated With Inotuzumab Ozogamicin Prior to Hematopoietic Stem Cell Transplantation 21
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience 18
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching 18
Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse 18
Erratum: Lung ultrasound to evaluate invasive fungal diseases after allogeneic hematopoietic stem cell transplantation (Infection and Chemotherapy (2019) 51: 4 (386-392) DOI: 10.3947/ic.2019.51.4.386) 17
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 17
Coadministration of letermovir and sirolimus in allogeneic hematopoietic cell transplant recipients 17
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 15
Ruxolitinib for chronic steroid-refractory graft versus host disease: a single center experience 15
Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia 14
Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: A single center experience 12
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients 11
Intrabone Transplantation of a Single Unwashed Umbilical Cord Blood Unit with Antithymocyte Globulin-Free and Sirolimus-Based Graft-versus-Host Disease Prophylaxis: Fast Immune Reconstitution and Long-Term Disease Control in Patients with High-Risk Diseases 10
Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients 3
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies 2
Totale 557
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.681
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 2 1 2 1 0 0 0 0 0
2021/202219 0 0 0 4 0 1 0 7 4 0 0 3
2022/2023162 21 16 6 4 23 18 6 19 15 9 17 8
2023/2024248 15 17 32 34 27 52 4 31 0 10 3 23
2024/2025122 44 23 25 18 12 0 0 0 0 0 0 0
Totale 557